Dr. Kabir Harricharan Singh, MD
NPI: 1588919518
Total Payments
$55,081
2024 Payments
$1,587
Companies
58
Transactions
1,097
Medicare Patients
2,477
Medicare Billing
$252,087
Payment Breakdown by Category
Other$34,125 (62.0%)
Food & Beverage$14,204 (25.8%)
Consulting$3,500 (6.4%)
Travel$2,423 (4.4%)
Education$828.64 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,125 | 44 | 62.0% |
| Food and Beverage | $14,204 | 990 | 25.8% |
| Consulting Fee | $3,500 | 2 | 6.4% |
| Travel and Lodging | $2,423 | 28 | 4.4% |
| Education | $828.64 | 33 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $42,254 | 269 | $0 (2024) |
| Novo Nordisk Inc | $2,613 | 188 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,310 | 119 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,221 | 48 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $922.62 | 52 | $0 (2022) |
| PFIZER INC. | $745.68 | 73 | $0 (2024) |
| GlaxoSmithKline, LLC. | $667.29 | 47 | $0 (2024) |
| Amgen Inc. | $581.55 | 51 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $579.29 | 26 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $487.98 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,587 | 103 | Novo Nordisk Inc ($521.05) |
| 2023 | $1,549 | 129 | Novo Nordisk Inc ($327.27) |
| 2022 | $1,048 | 73 | Novo Nordisk Inc ($231.88) |
| 2021 | $848.48 | 69 | Novo Nordisk Inc ($319.64) |
| 2020 | $3,470 | 79 | Lilly USA, LLC ($2,680) |
| 2019 | $39,396 | 187 | Lilly USA, LLC ($38,628) |
| 2018 | $2,911 | 214 | AstraZeneca Pharmaceuticals LP ($495.79) |
| 2017 | $4,271 | 243 | Novo Nordisk Inc ($456.83) |
All Payment Transactions
1,097 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: GALLSTONES | ||||||
| 12/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: Obesity | ||||||
| 11/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: GALLSTONES | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Obesity | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Obesity | ||||||
| 09/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Inflammation | ||||||
| 09/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: GALLSTONES | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 638 | 873 | $105,792 | $42,551 |
| 2022 | 10 | 445 | 738 | $139,380 | $64,177 |
| 2021 | 13 | 662 | 985 | $167,585 | $77,204 |
| 2020 | 16 | 732 | 1,073 | $167,040 | $68,154 |
Total Patients
2,477
Total Services
3,669
Medicare Billing
$252,087
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 90 | 179 | $51,405 | $20,451 | 39.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $7,350 | $5,365 | 73.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 53 | $11,430 | $3,977 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $5,610 | $3,628 | 64.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 35 | 35 | $6,490 | $2,398 | 37.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 54 | 81 | $4,050 | $838.35 | 20.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 45 | 65 | $3,640 | $835.24 | 22.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 32 | 43 | $2,924 | $686.76 | 23.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 59 | 88 | $2,992 | $669.68 | 22.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $800.00 | $625.68 | 78.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $700.00 | $540.36 | 77.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 23 | 23 | $720.00 | $480.18 | 66.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 21 | 28 | $1,316 | $424.87 | 32.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 22 | 26 | $1,716 | $384.28 | 22.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 24 | 25 | $875.00 | $375.75 | 42.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 31 | $1,457 | $295.12 | 20.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 28 | $980.00 | $252.22 | 25.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 32 | 35 | $700.00 | $193.95 | 27.7% |
| 84550 | Uric acid level, blood | Office | 2023 | 22 | 23 | $391.00 | $94.23 | 24.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 16 | $246.00 | $35.20 | 14.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 109 | 305 | $80,825 | $37,211 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 111 | 111 | $23,310 | $13,682 | 58.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 123 | $23,985 | $9,094 | 37.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 29 | 39 | $2,535 | $904.90 | 35.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 16 | 26 | $3,640 | $853.83 | 23.5% |
About Dr. Kabir Harricharan Singh, MD
Dr. Kabir Harricharan Singh, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Newport, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2012. The National Provider Identifier (NPI) number assigned to this provider is 1588919518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kabir Harricharan Singh, MD has received a total of $55,081 in payments from pharmaceutical and medical device companies, with $1,587 received in 2024. These payments were reported across 1,097 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,125).
As a Medicare-enrolled provider, Harricharan Singh has provided services to 2,477 Medicare beneficiaries, totaling 3,669 services with total Medicare billing of $252,087. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Newport, TN
- Active Since 07/16/2012
- Last Updated 02/04/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1588919518
Products in Payments
- TRULICITY (Drug) $41,486
- JARDIANCE (Drug) $1,257
- XARELTO (Drug) $816.44
- Ozempic (Drug) $807.75
- FARXIGA (Drug) $566.36
- ENTRESTO (Drug) $405.23
- Otezla (Drug) $397.09
- ELIQUIS (Drug) $383.32
- Saxenda (Drug) $365.64
- Wegovy (Drug) $306.48
- TOUJEO (Drug) $276.04
- Rybelsus (Drug) $252.94
- MOUNJARO (Drug) $252.25
- Victoza (Drug) $241.21
- VRAYLAR (Drug) $212.56
- SOLIQUA (Drug) $212.54
- Vascepa (Drug) $209.10
- Movantik (Drug) $201.21
- ANORO (Drug) $181.66
- TRELEGY ELLIPTA (Drug) $178.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Newport
Lindsay Henderson, Np, NP
Student in an Organized Health Care Education/Training Program — Payments: $8,576
Student in an Organized Health Care Education/Training Program $8,576
Dr. Michael Wehmann, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2,463
Student in an Organized Health Care Education/Training Program $2,463
Dr. Samantha Bartling, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $1,401
Student in an Organized Health Care Education/Training Program $1,401
Dr. Matthew Lunati
Student in an Organized Health Care Education/Training Program — Payments: $708.95
Student in an Organized Health Care Education/Training Program $708.95
Sarah Millikin, Od, OD
Student in an Organized Health Care Education/Training Program — Payments: $238.93
Student in an Organized Health Care Education/Training Program $238.93
Walter Wilson, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $237.49
Student in an Organized Health Care Education/Training Program $237.49